NCS-MPP (4-(2′-METHOXY-PHENYL)-1-[2′-(N-2″-PYRIDYL)-P-Isothiocyanobenzamido]-Ethyl-Piperazine): A high affinity and irreversible 5-HT1A receptor ligand
作者:Mei-Ping Kung、Mu Mu、Zhi-Ping Zhuang、Hank F. Kung
DOI:10.1016/0024-3205(95)02275-9
日期:1995.12
A novel irreversible 5-HT1A receptor binding ligand, NCS-MPP (4-(2'- methoxy-phenyl)-1-[2'-(N-2"-pyridyl)-p-isothiocyanobenzamido]- ethyl-piperazine), based on the new5-HT1A receptor antagonist p-MPPI (4-(2'-methoxy-phenyl)-1-[2'-(N-2"-pyridyl)-p-iodobenzamido]-ethyl -piperazine ), was synthesized, and its binding characteristics were evaluated using in vitro homogenate binding with rat hippocampal
Derivatives of 4-(2'-Methoxyphenyl)-1-[2'-(N-2''-pyridinyl-p-iodobenzamido)ethyl]piperazine (p-MPPI) as 5-HT1A Ligands
作者:Zhi-Ping Zhuang、Mei-Ping Kung、Sumalee Chumpradit、Mu Mu、Hank F. Kung
DOI:10.1021/jm00052a018
日期:1994.12
A series of new p-alkylbenzamido derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)-p- iodobenzamido)ethyl]piperazines (p-MPPI) were prepared. In vitro binding studies suggest that p-methyl and p-ethyl substituents on the benzamido group display the same high binding affinity to 5-HT1A receptors (Ki = 2.2 and 9.3 nM, rat hippocampal homogenates). However, when the substitution groups were larger